Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT05934305

Mitigating the Impact of Stigma and Shame Among People Living With HIV and Substance Use Disorders

Led by Boston University · Updated on 2026-05-13

256

Participants Needed

2

Research Sites

168 weeks

Total Duration

On this page

Sponsors

B

Boston University

Lead Sponsor

N

National Institute on Drug Abuse (NIDA)

Collaborating Sponsor

AI-Summary

What this Trial Is About

People living with HIV and substance use disorders (SUDs) are less likely to be virally suppressed, which can lead to HIV transmission and negative health outcomes. This hybrid type 1 study will assess the efficacy, mechanisms, as well as facilitators and barriers to implementing the MATTER intervention, a virtually delivered 5-session text-enhanced psychobehavioral intervention designed to facilitate viral suppression by addressing internalized stigma and shame as barriers to engagement in HIV care among individuals living with HIV and SUDs in two locations with different levels of HIV resources (i.e., the Boston, Massachusetts and Miami, Florida metro areas). MATTER aims to mitigate the negative behavioral consequences of internalized stigma and shame on viral suppression by a) developing behavioral self-care goal setting skills and related self-efficacy, b) increasing metacognitive awareness (i.e., non-judgmental awareness of emotions and cognitions), and c) teaching and reinforcing compassionate self-restructuring (i.e., self- compassion), in addition to providing access to phone-based resource navigation. Scalable interventions such as MATTER are essential to our efforts to end the HIV epidemic in high priority regions.

CONDITIONS

Official Title

Mitigating the Impact of Stigma and Shame Among People Living With HIV and Substance Use Disorders

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • HIV positive status
  • Have a substance use disorder excluding only tobacco, cannabis, or alcohol
  • Experience internalized stigma related to HIV, substance use, sexual orientation, or gender identity
  • Have had a detectable viral load in the past year or report low adherence to oral or injectable ART as defined
  • Be at least 18 years old
  • Provide informed consent in English
  • Be able to read and speak English or Spanish
  • Provide proof of HIV positive status
  • Agree to release HIV-related health records
  • Have access to a cell phone with text messaging capabilities (phones and plans may be provided if needed)
Not Eligible

You will not qualify if you...

  • HIV negative status

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

Florida International University

Miami, Florida, United States, 33199

Actively Recruiting

2

Fenway Health

Boston, Massachusetts, United States, 02215

Actively Recruiting

Loading map...

Research Team

A

Abigail Batchelder, PhD, MPH

CONTACT

A

Alexandria Miller, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here